We are live on ! Find out more
DG

Delek Group Portfolio holdings

AUM $2.59B
1-Year Est. Return 1.24%
This Fund
S&P 500
This Quarter Est. Return
-16.41%
1 Year Est. Return
-1.24%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$2.19B
AUM Growth
-$191M
Cap. Flow
+$144M
Cap. Flow %
6.58%
Top 10 Hldgs %
23.34%
Holding
263
New
37
Increased
74
Reduced
71
Closed
47

Sector Composition

Rank Sector Weight
1 Miscellaneous 21.98%
2 Technology 16.06%
3 Healthcare 14.03%
4 Materials 8.78%
5 Energy 8.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SAVE
251
DELISTED
Spirit Airlines, Inc.
SAVE
-64,500
Closed -$3.01M
CLVS
252
DELISTED
Clovis Oncology, Inc.
CLVS
-42,000
Closed -$1.23M
NBL
253
CALL
DELISTED
Noble Energy, Inc.
NBL
-535,000
Closed -$14M
ARCH
254
DELISTED
Arch Resources, Inc.
ARCH
-43,320
Closed -$3.85M
AGN
255
DELISTED
Allergan plc
AGN
-100,746
Closed -$19.1M
APC
256
DELISTED
Anadarko Petroleum
APC
-9,000
Closed -$603K
GZT
257
DELISTED
Gazit-globe Ltd
GZT
-144,062
Closed -$1.35M
ORBK
258
DELISTED
Orbotech Ltd
ORBK
-787,471
Closed -$46.5M
TSRO
259
DELISTED
TESARO, Inc.
TSRO
-30,000
Closed -$1.16M
SODA
260
CALL
DELISTED
SodaStream International Ltd
SODA
-32,500
Closed -$4.65M
AET
261
DELISTED
Aetna Inc
AET
-26,150
Closed -$5.27M

Similar funds

Delek Group's Q4 2018 Portfolio in Review

As of Q4 2018, Delek Group held 263 positions worth $2.19B, down 8% from $2.38B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Delek Group deployed $144M of net new capital in Q4 2018, opening 37 new positions and adding to 74 existing holdings. Its largest new stake was DuPont de Nemours: 177,858 shares worth $24.7M.

By sector, the portfolio is most concentrated in Miscellaneous at 22% of assets, down from 23% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was iShares MSCI Emerging Markets ETF, an estimated $30.8M trimmed.

  • Delek Group's largest Q4 2018 buy was DuPont de Nemours: 177,858 shares worth $24.7M.
  • Delek Group added most to Teva Pharmaceuticals in Q4 2018, an estimated $36.2M increase.
  • Delek Group's biggest Q4 2018 reduction was iShares MSCI Emerging Markets ETF, cutting an estimated $30.8M.
  • Delek Group fully exited Orbotech Ltd in Q4 2018, selling an estimated $46.5M.
  • Delek Group's ten largest holdings make up 23% of its $2.19B portfolio in Q4 2018.
  • Delek Group opened 37 new positions and closed 47 in Q4 2018.
  • Delek Group's portfolio value fell 8% quarter-over-quarter to $2.19B.

Based on Delek Group's 13F filing for Q4 2018, filed 14 Feb 2019.